These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
28. Future treatment of peptic ulcer: is there room for anti-infective drugs? Dajani EZ J Physiol Pharmacol; 1993 Mar; 44(1):3-6. PubMed ID: 8518423 [TBL] [Abstract][Full Text] [Related]
29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
30. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
31. [Drug therapy of peptic ulcer. What is coming up?]. Müller P; Dammann HG; Simon B; Kommerell B Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707 [TBL] [Abstract][Full Text] [Related]
32. The limitations of current therapy in peptic ulcer disease. Salena BJ; Hunt RH Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747 [TBL] [Abstract][Full Text] [Related]
33. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?]. Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172 [TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of duodenal ulcer. Wormsley KG Postgrad Med J; 1988; 64 Suppl 1():47-53. PubMed ID: 3047725 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153 [TBL] [Abstract][Full Text] [Related]
36. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings]. Gostishchev VK; Evseev MA Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681 [TBL] [Abstract][Full Text] [Related]
37. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence. Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995 [TBL] [Abstract][Full Text] [Related]
38. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. Florent C Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399 [TBL] [Abstract][Full Text] [Related]